Literature DB >> 21700394

Identification of Theileria parva and Theileria sp. (buffalo) 18S rRNA gene sequence variants in the African Buffalo (Syncerus caffer) in southern Africa.

Mamohale E Chaisi1, Kgomotso P Sibeko, Nicola E Collins, Fred T Potgieter, Marinda C Oosthuizen.   

Abstract

Theileria parva is the causative agent of Corridor disease in cattle in South Africa. The African buffalo (Syncerus caffer) is the reservoir host, and, as these animals are important for eco-tourism in South Africa, it is compulsory to test and certify them disease free prior to translocation. A T. parva-specific real-time polymerase chain reaction (PCR) test based on the small subunit ribosomal RNA (18S rRNA) gene is one of the tests used for the diagnosis of the parasite in buffalo and cattle in South Africa. However, because of the high similarity between the 18S rRNA gene sequences of T. parva and Theileria sp. (buffalo), the latter is also amplified by the real-time PCR primers, although it is not detected by the T. parva-specific hybridization probes. Preliminary sequencing studies have revealed a small number of sequence differences within the 18S rRNA gene in both species but the extent of this sequence variation is unknown. The aim of the current study was to sequence the 18S rRNA genes of T. parva and Theileria sp. (buffalo), and to determine whether all identified genotypes can be correctly detected by the real-time PCR assay. The reverse line blot (RLB) hybridization assay was used to identify T. parva and Theileria sp. (buffalo) positive samples from buffalo blood samples originating from the Kruger National Park, Hluhluwe-iMfolozi Park, the Greater Limpopo Transfrontier Park, and a private game ranch in the Hoedspruit area. T. parva and Theileria sp. (buffalo) were identified in 42% and 28%, respectively, of 252 samples, mainly as mixed infections. The full-length 18S rRNA gene of selected samples was amplified, cloned and sequenced. From a total of 20 sequences obtained, 10 grouped with previously published T. parva sequences from GenBank while 10 sequences grouped with a previously published Theileria sp. (buffalo) sequence. All these formed a monophyletic group with known pathogenic Theileria species. Our phylogenetic analyses confirm the distinction between Theileria sp. (buffalo) and T. parva and indicate the existence of a single group of T. parva and two Theileria sp. (buffalo) 18S rRNA gene variants in the African buffalo. Despite the observed variation in the full-length parasite 18S rRNA gene sequences, the area in the V4 hypervariable region where the RLB and real-time PCR hybridization probes were developed was relatively conserved. The T. parva specific real-time PCR assay was able to successfully detect all T. parva variants and, although amplicons were obtained from Theileria sp. (buffalo) DNA, none of the Theileria sp. (buffalo) 18S rRNA sequence variants were detected by the T. parva-specific hybridization probes.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21700394     DOI: 10.1016/j.vetpar.2011.05.041

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  14 in total

1.  The first molecular identification and phylogenetic analysis of tick-borne pathogens in captive wild animals from Lohi Bher zoo, Pakistan.

Authors:  Muhammad Uzair Mukhtar; Naveed Iqbal; Jifei Yang; Zeeshan Nawaz; Tan Li Peng
Journal:  Parasitol Res       Date:  2022-09-17       Impact factor: 2.383

Review 2.  A review of wildlife tourism and meta-analysis of parasitism in Africa's national parks and game reserves.

Authors:  Paul Olalekan Odeniran; Isaiah Oluwafemi Ademola; Henry Olanrewaju Jegede
Journal:  Parasitol Res       Date:  2018-06-14       Impact factor: 2.383

3.  Tick-borne haemoparasites in African buffalo (Syncerus caffer) from two wildlife areas in Northern Botswana.

Authors:  Dewald Eygelaar; Ferran Jori; Mokganedi Mokopasetso; Kgomotso P Sibeko; Nicola E Collins; Ilse Vorster; Milana Troskie; Marinda C Oosthuizen
Journal:  Parasit Vectors       Date:  2015-01-15       Impact factor: 3.876

4.  Identification of novel Theileria genotypes from Grant's gazelle.

Authors:  Janis Hooge; Laryssa Howe; Vanessa O Ezenwa
Journal:  Int J Parasitol Parasites Wildl       Date:  2015-04-30       Impact factor: 2.674

5.  History and development of research on wildlife parasites in southern Africa, with emphasis on terrestrial mammals, especially ungulates.

Authors:  Kerstin Junker; Ivan G Horak; Banie Penzhorn
Journal:  Int J Parasitol Parasites Wildl       Date:  2014-12-24       Impact factor: 2.674

Review 6.  A review of Theileria diagnostics and epidemiology.

Authors:  Ben J Mans; Ronel Pienaar; Abdalla A Latif
Journal:  Int J Parasitol Parasites Wildl       Date:  2015-01-06       Impact factor: 2.674

7.  First Molecular Detection of Babesia gibsoni in Dogs from Wuhan, China.

Authors:  Lan He; Xiaoyan Miao; Jinfang Hu; Yuan Huang; Pei He; Junwei He; Long Yu; Ngabu Malobi; Ligang Shi; Junlong Zhao
Journal:  Front Microbiol       Date:  2017-08-21       Impact factor: 5.640

8.  Ancient diversity and geographical sub-structuring in African buffalo Theileria parva populations revealed through metagenetic analysis of antigen-encoding loci.

Authors:  Johanneke D Hemmink; Tatjana Sitt; Roger Pelle; Lin-Mari de Klerk-Lorist; Brian Shiels; Philip G Toye; W Ivan Morrison; William Weir
Journal:  Int J Parasitol       Date:  2018-02-03       Impact factor: 3.981

9.  Molecular and Phylogenetic analysis revealed new genotypes of Theileria annulata parasites from India.

Authors:  Neena George; Vasundhra Bhandari; D Peddi Reddy; Paresh Sharma
Journal:  Parasit Vectors       Date:  2015-09-17       Impact factor: 3.876

10.  Evaluation of a real-time PCR test for the detection and discrimination of theileria species in the African buffalo (Syncerus caffer).

Authors:  Mamohale E Chaisi; Michiel E Janssens; Lieve Vermeiren; Marinda C Oosthuizen; Nicola E Collins; Dirk Geysen
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.